KY
Kyntra Bio, Inc. (KYNB)
NASDAQ·Healthcare·Medical - Pharmaceuticals
$7.92
-0.69%
Mkt Cap $29.69M
Analyst Ratings
No recent rating data.
Price Target (1 analysts)
$28.00
Range $28.00 – $28.00
Implied Upside
+253.5%
Consensus $28.00 vs current $7.92